This Article Full Text Full Text (PDF) Alert me when this article is cited Alert me if a correction is posted Services Similar articles in this journal Similar articles in PubMed Alert me to new issues of the journal Download to citation manager Copyright Information Books from ASM Press MicrobeWorld Citing Articles Citing Articles via HighWire Citing Articles via Google Scholar Google Scholar Articles by Bartkus, J. M. Articles by Besser, J. M. Search for Related Content PubMed PubMed Citation Articles by Bartkus, J. M. Articles by Besser, J. M.

Identification of a Mutation Associated with Erythromycin Resistance in Bordetella pertussis: Implications for Surveillance of Antimicrobial Resistance

Minnesota Department of Health, Minneapolis,¹ Crossroads Medical Center, Chaska, Minnesota,⁶ Centers for Disease Control and Prevention,² Children's Hospital, Atlanta, Georgia,⁵ Good Samaritan Medical Center, Phoenix, Arizona,³ Oakland Children's Hospital, Oakland, California⁴

Received 10 September 2002/ Returned for modification 25 October 2002/ Accepted 17 December 2002

Erythromycin treatment failures and in vitro resistance of Bordetella pertussis have been reported on several occasions in the past few years, but the mechanism of resistance has not been described. One potential mechanism, genetic modification of the erythromycin-binding site on the 23S rRNA of the 50S ribosomal subunit, has been observed in other bacteria. To explore this possibility, we amplified the portion of the 23S rRNA gene encoding the central loop of domain V. DNA sequencing and restriction fragment length polymorphism of the PCR products showed that each of the four erythromycin-resistant B. pertussis strains tested contained an A-to-G transition mutation at position 2058 (Escherichia coli numbering) of the 23S rRNA gene. The mutation was not found in seven erythromycin-susceptible isolates tested. Two of the resistant isolates were heterozygous, containing at least one mutant copy and one wild-type copy of the 23S rRNA gene. These results indicate that erythromycin resistance in these strains is likely due to a mutation of the erythromycin-binding site in the 23S rRNA gene. Identification of the resistance mechanism will facilitate development of molecular susceptibility testing methods that can be used directly on clinical specimens in the absence of an isolate.

Present address: Park Nicollet Heart Center, Saint Louis Park, Minn.

This article has been cited by other articles:

• Cassiday, P. K., Tobin-D'Angelo, M., Watson, J. R., Wu, K.-H., Park, M. M., Sanden, G. N. (2008). Co-infection with two different strains of Bordetella pertussis in an infant. J Med Microbiol 57: 388-391 [Abstract] [Full Text]  
• Binet, R., Maurelli, A. T. (2007). Frequency of Development and Associated Physiological Cost of Azithromycin Resistance in Chlamydia psittaci 6BC and C. trachomatis L2. Antimicrob. Agents Chemother. 51: 4267-4275 [Abstract] [Full Text]  
• Sintchenko, V., Brown, M., Gilbert, G. L. (2007). Is Bordetella pertussis susceptibility to erythromycin changing? MIC trends among Australian isolates 1971 2006. J Antimicrob Chemother 60: 1178-1179 [Full Text]  
• Bonacorsi, S., Farnoux, C., Bidet, P., Caro, V., Aizenfisz, S., Benhayoun, M., Aujard, Y., Guiso, N., Bingen, E. (2006). Treatment failure of nosocomial pertussis infection in a very-low-birth-weight neonate.. J. Clin. Microbiol. 44: 3830-3832 [Abstract] [Full Text]  
• Binet, R., Maurelli, A. T. (2005). Frequency of Spontaneous Mutations That Confer Antibiotic Resistance in Chlamydia spp.. Antimicrob. Agents Chemother. 49: 2865-2873 [Abstract] [Full Text]  
• Mishra, M., Parise, G., Jackson, K. D., Wozniak, D. J., Deora, R. (2005). The BvgAS Signal Transduction System Regulates Biofilm Development in Bordetella. J. Bacteriol. 187: 1474-1484 [Abstract] [Full Text]